1. Home
  2. HOWL vs OPTX Comparison

HOWL vs OPTX Comparison

Compare HOWL & OPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • OPTX
  • Stock Information
  • Founded
  • HOWL 2017
  • OPTX 1981
  • Country
  • HOWL United States
  • OPTX United States
  • Employees
  • HOWL N/A
  • OPTX N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • OPTX Blank Checks
  • Sector
  • HOWL Health Care
  • OPTX Finance
  • Exchange
  • HOWL Nasdaq
  • OPTX Nasdaq
  • Market Cap
  • HOWL 50.3M
  • OPTX 51.9M
  • IPO Year
  • HOWL 2021
  • OPTX N/A
  • Fundamental
  • Price
  • HOWL $1.20
  • OPTX $1.68
  • Analyst Decision
  • HOWL Strong Buy
  • OPTX
  • Analyst Count
  • HOWL 3
  • OPTX 0
  • Target Price
  • HOWL $8.33
  • OPTX N/A
  • AVG Volume (30 Days)
  • HOWL 643.1K
  • OPTX 56.1K
  • Earning Date
  • HOWL 05-08-2025
  • OPTX 06-13-2025
  • Dividend Yield
  • HOWL N/A
  • OPTX N/A
  • EPS Growth
  • HOWL N/A
  • OPTX N/A
  • EPS
  • HOWL N/A
  • OPTX 0.00
  • Revenue
  • HOWL $1,143,000.00
  • OPTX $29,392,186.00
  • Revenue This Year
  • HOWL N/A
  • OPTX N/A
  • Revenue Next Year
  • HOWL $900.00
  • OPTX N/A
  • P/E Ratio
  • HOWL N/A
  • OPTX $997.14
  • Revenue Growth
  • HOWL N/A
  • OPTX 4.36
  • 52 Week Low
  • HOWL $0.60
  • OPTX $0.85
  • 52 Week High
  • HOWL $5.73
  • OPTX $8.39
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 61.01
  • OPTX 57.15
  • Support Level
  • HOWL $1.18
  • OPTX $1.61
  • Resistance Level
  • HOWL $1.31
  • OPTX $1.85
  • Average True Range (ATR)
  • HOWL 0.11
  • OPTX 0.16
  • MACD
  • HOWL 0.02
  • OPTX 0.01
  • Stochastic Oscillator
  • HOWL 68.83
  • OPTX 60.86

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

Share on Social Networks: